1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Facial Injectables Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Facial Injectables Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Forces Analysis
5. Key Insights
5.1. Technological Advancements
5.2. Pricing Analysis
5.3. Key Mergers & Acquisitions
5.4. Top 3 Players Operating in the Market Space
5.5. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Facial Injectables Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017-2031
6.3.1. Collagen
6.3.2. Hyaluronic Acid (HA)
6.3.3. Botulinum Toxin Type A
6.3.4. Calcium Hydroxylapatite (CaHA)
6.3.5. Polymethylmethacrylate Beads (PMMA Microspheres)
6.3.6. Poly-L-Lactic Acid (PLLA)
6.3.7. Others (Polyalkylimide )
6.4. Market Attractiveness Analysis, by Product Type
7. Global Facial Injectables Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017-2031
7.3.1. Facial Line Correction
7.3.2. Lip Augmentation
7.3.3. Acne Scar Treatment
7.3.4. Face Lift
7.3.5. Lipoatrophy Treatment
7.3.6. Others (earlobe rejuvenation)
7.4. Market Attractiveness Analysis, by Application
8. Global Facial Injectables Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017-2031
8.3.1. Hospitals
8.3.2. Dermatology Clinics
8.3.3. Others (beauty clinics)
8.4. Market Attractiveness Analysis, by End-user
9. Global Facial Injectables Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017-2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Facial Injectables Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017-2031
10.2.1. Collagen
10.2.2. Hyaluronic Acid (HA)
10.2.3. Botulinum Toxin Type A
10.2.4. Calcium Hydroxylapatite (CaHA)
10.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
10.2.6. Poly-L-Lactic Acid (PLLA)
10.2.7. Others (Polyalkylimide)
10.3. Market Value Forecast, by Application, 2017-2031
10.3.1. Facial Line Correction
10.3.2. Lip Augmentation
10.3.3. Acne Scar Treatment
10.3.4. Face Lift
10.3.5. Lipoatrophy Treatment
10.3.6. Others (earlobe rejuvenation)
10.4. Market Value Forecast, by End-user, 2017-2031
10.4.1. Hospitals
10.4.2. Dermatology Clinics
10.4.3. Others (Beauty Clinics)
10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Facial Injectables Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017-2031
11.2.1. Collagen
11.2.2. Hyaluronic Acid (HA)
11.2.3. Botulinum Toxin Type A
11.2.4. Calcium Hydroxylapatite (CaHA)
11.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
11.2.6. Poly-L-Lactic Acid (PLLA)
11.2.7. Others (Polyalkylimide)
11.3. Market Value Forecast, by Application, 2017-2031
11.3.1. Facial Line Correction
11.3.2. Lip Augmentation
11.3.3. Acne Scar Treatment
11.3.4. Face Lift
11.3.5. Lipoatrophy Treatment
11.3.6. Others (earlobe rejuvenation)
11.4. Market Value Forecast, by End-user, 2017-2031
11.4.1. Hospitals
11.4.2. Dermatology Clinics
11.4.3. Others (beauty clinics)
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Facial Injectables Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017-2031
12.2.1. Collagen
12.2.2. Hyaluronic Acid (HA)
12.2.3. Botulinum Toxin Type A
12.2.4. Calcium Hydroxylapatite (CaHA)
12.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
12.2.6. Poly-L-Lactic Acid (PLLA)
12.2.7. Others (Polyalkylimide)
12.3. Market Value Forecast, by Application, 2017-2031
12.3.1. Facial Line Correction
12.3.2. Lip Augmentation
12.3.3. Acne Scar Treatment
12.3.4. Face Lift
12.3.5. Lipoatrophy Treatment
12.3.6. Others (earlobe rejuvenation)
12.4. Market Value Forecast, by End-user, 2017-2031
12.4.1. Hospitals
12.4.2. Dermatology Clinics
12.4.3. Others (beauty clinics)
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Facial Injectables Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017-2031
13.2.1. Collagen
13.2.2. Hyaluronic Acid (HA)
13.2.3. Botulinum Toxin Type A
13.2.4. Calcium Hydroxylapatite (CaHA)
13.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
13.2.6. Poly-L-Lactic Acid (PLLA)
13.2.7. Others (Polyalkylimide)
13.3. Market Value Forecast, by Application, 2017-2031
13.3.1. Facial Line Correction
13.3.2. Lip Augmentation
13.3.3. Acne Scar Treatment
13.3.4. Face Lift
13.3.5. Lipoatrophy Treatment
13.3.6. Others (earlobe rejuvenation)
13.4. Market Value Forecast, by End-user, 2017-2031
13.4.1. Hospitals
13.4.2. Dermatology Clinics
13.4.3. Others (beauty clinics)
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Facial Injectables Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017-2031
14.2.1. Collagen
14.2.2. Hyaluronic Acid (HA)
14.2.3. Botulinum Toxin Type A
14.2.4. Calcium Hydroxylapatite (CaHA)
14.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
14.2.6. Poly-L-Lactic Acid (PLLA)
14.2.7. Others (Polyalkylimide)
14.3. Market Value Forecast, by Application, 2017-2031
14.3.1. Facial Line Correction
14.3.2. Lip Augmentation
14.3.3. Acne Scar Treatment
14.3.4. Face Lift
14.3.5. Lipoatrophy Treatment
14.3.6. Others (earlobe rejuvenation)
14.4. Market Value Forecast, by End-user, 2017-2031
14.4.1. Hospitals
14.4.2. Dermatology Clinics
14.4.3. Others (beauty clinics)
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company (2021)
15.3. Company Profiles
15.3.1. Allergan, Inc.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Ipsen (Mayroy SA)
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Merz Pharma
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Suneva Medical, Inc.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Medytox Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Sinclair Pharma
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Bloomage BioTechnology
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Anika Therapeutics, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Prollenium Medical Technologies
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.10. Galderma
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
